{
  "docId": "019de071-94a0-75ef-b86b-e4894fa7dc1d",
  "docSlug": "8b4d61768a47893d5f24ee0f1f9ae717",
  "documentTitle": "argenx SE | Results Presentation Deck | 20 slides",
  "authorId": "argenx-se",
  "authorName": "argenx",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 9,
  "pageCount": 20,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "appendix_methodology",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 2,
  "notes": "The slide outlines a clinical trial process flow.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de071-94a0-75ef-b86b-e4894fa7dc1d/9",
  "deckHref": "/decks/019de071-94a0-75ef-b86b-e4894fa7dc1d",
  "deckJsonHref": "/decks/019de071-94a0-75ef-b86b-e4894fa7dc1d.json",
  "deckAnchorHref": "/decks/019de071-94a0-75ef-b86b-e4894fa7dc1d#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.7,
        "x": 0.05,
        "y": 0.025
      },
      "kind": "diagram",
      "text": "Screening to Randomization process flow",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e790e0a-064d-4bba-82e4-45f8fbb42e30",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.2,
        "x": 0.78,
        "y": 0.3
      },
      "kind": "list",
      "text": "Primary endpoint is proportion of PV patients achieving CRmin* within 30 weeks. N=sample size estimation ≤150 patients (PV and PF) with PF patients capped. Followed by Open Label Extension study",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "adbf2ac1-b38a-424f-88e6-52585953f591",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.05,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "CR=complete clinical remission; CRmin=complete remission on minimal therapy; EoC=end of consolidation; SC=subcutaneous.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9682349f-8e7d-4aa5-9c65-1eceb3693f71",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Pemphigus: Registrational Trial Focused on Fast Onset and Steroid-sparing",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "38c1a5f8-cc36-4c63-a4e4-1f9727e3f4bf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "fe7c5599-f84e-435c-88f3-8fb6e6ceae94",
      "evidence": "The slide depicts a sequential clinical trial workflow from screening to randomization.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 7,
      "beatId": "3c157cf2-a15a-4adb-bf74-d8b7db4a16f5",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "What Is",
      "beatSlug": "sparkline-what-is-3",
      "evidence": "The roadmap slides present the current pipeline and development plans",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}